Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.43B |
| 2 |
Apple
AAPL
|
+$1.09B |
| 3 |
Tesla
TSLA
|
+$984M |
| 4 |
NVIDIA
NVDA
|
+$826M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
+$768M |
Top Sells
| 1 |
Technology Select Sector SPDR Fund
XLK
|
+$307M |
| 2 |
Willis Towers Watson
WTW
|
+$257M |
| 3 |
Advanced Micro Devices
AMD
|
+$238M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$227M |
| 5 |
PPD
PPD, Inc. Common Stock
PPD
|
+$206M |
Sector Composition
| 1 | Technology | 17.11% |
| 2 | Financials | 14.3% |
| 3 | Healthcare | 13.21% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
1601
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $9.46M | ﹤0.01% |
534,349
+358,407
| +204% | +$6.35M |
|
1602
Center Bancorp
CNOB
$1.26B
| $9.45M | ﹤0.01% |
289,025
+254,511
| +737% | +$8.33M |
|
|
TGH
1603
DELISTED
Textainer Group Holdings limited
TGH
| $9.42M | ﹤0.01% |
263,823
+128,281
| +95% | +$4.58M |
|
1604
Metropolitan Bank Holding Corp
MCB
$807M
| $9.39M | ﹤0.01% |
88,158
+37,111
| +73% | +$3.95M |
|
1605
Pacific Biosciences
PACB
$351M
| $9.38M | ﹤0.01% |
458,404
+69,124
| +18% | +$1.41M |
|
1606
Exelixis
EXEL
$10.5B
| $9.37M | ﹤0.01% |
512,609
+123,212
| +32% | +$2.25M |
|
1607
Armstrong World Industries
AWI
$8.5B
| $9.37M | ﹤0.01% |
80,649
+69,741
| +639% | +$8.1M |
|
1608
Arcos Dorados Holdings
ARCO
$1.43B
| $9.36M | ﹤0.01% |
1,604,579
+983,796
| +158% | +$5.74M |
|
|
BNT
1609
Brookfield Wealth Solutions Ltd.
BNT
$19.3B
| $9.34M | ﹤0.01% |
148,611
+110,151
| +286% | +$6.92M |
|
1610
Trade Desk
TTD
$22.1B
| $9.33M | ﹤0.01% |
101,776
-95,322
| -48% | -$8.74M |
|
1611
Frontier Group Holdings
ULCC
$1.18B
| $9.3M | ﹤0.01% |
685,339
+428,670
| +167% | +$5.82M |
|
|
BCYC
1612
Bicycle Therapeutics
BCYC
$490M
| $9.3M | ﹤0.01% |
+152,732
| New | +$9.3M |
|
1613
SunCoke Energy
SXC
$654M
| $9.29M | ﹤0.01% |
1,409,030
+149,709
| +12% | +$987K |
|
1614
LivePerson
LPSN
$86M
| $9.29M | ﹤0.01% |
259,943
+166,056
| +177% | +$5.93M |
|
1615
Boston Properties
BXP
$12.2B
| $9.28M | ﹤0.01% |
80,531
+74,764
| +1,296% | +$8.61M |
|
|
CNDB.U
1616
DELISTED
Concord Acquisition Corp III Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
CNDB.U
| $9.27M | ﹤0.01% |
+910,000
| New | +$9.27M |
|
1617
Vermilion Energy
VET
$1.14B
| $9.27M | ﹤0.01% |
736,796
+699,025
| +1,851% | +$8.8M |
|
|
MAXR
1618
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $9.26M | ﹤0.01% |
313,667
+271,794
| +649% | +$8.03M |
|
1619
Brilliant Earth
BRLT
$37.2M
| $9.25M | ﹤0.01% |
512,218
-239,156
| -32% | -$4.32M |
|
|
NOVA
1620
DELISTED
Sunnova Energy
NOVA
| $9.24M | ﹤0.01% |
330,922
-86,435
| -21% | -$2.41M |
|
1621
1-800-Flowers.com
FLWS
$343M
| $9.23M | ﹤0.01% |
+394,903
| New | +$9.23M |
|
1622
Heron Therapeutics
HRTX
$193M
| $9.17M | ﹤0.01% |
+1,004,798
| New | +$9.17M |
|
1623
Oceaneering
OII
$2.43B
| $9.17M | ﹤0.01% |
810,633
+232,570
| +40% | +$2.63M |
|
1624
VEON
VEON
$3.71B
| $9.17M | ﹤0.01% |
214,444
-98,688
| -32% | -$4.22M |
|
|
MODV
1625
DELISTED
ModivCare
MODV
| $9.16M | ﹤0.01% |
61,741
+42,678
| +224% | +$6.33M |
|